Institutional Ownership
Kura Oncology Inc
CUSIP 50127T109COMKURAQ1 2026
13D / 13G Filings
64
Schedule 13D/13G on record
Beneficial Filers
21
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
210
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
64 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Armistice Capital, LLC | 13G/A | 5.7% | 4.94M | SEC |
| 2 | Feb 9, 2026 | State Street Corporation | 13G | 5.7% | 4.93M | SEC |
| 3 | Nov 14, 2025 | Armistice Capital, LLC | 13G/A | 5.4% | 4.67M | SEC |
| 4 | Nov 14, 2025 | Armistice Capital, LLC | 13G/A | 4.1% | 3.28M | SEC |
| 5 | Nov 14, 2025 | Biotechnology Value Fund L P | 13G/A | 10.0% | 8.68M | SEC |
| 6 | Aug 14, 2025 | Armistice Capital, LLC | 13G/A | 6.0% | 4.74M | SEC |
| 7 | Aug 14, 2025 | Ecor1 Capital, LLC | 13G/A | 4.8% | — | SEC |
| 8 | May 15, 2025 | Ra Capital Management, L.P. | 13G/A | 4.9% | 4.00M | SEC |
| 9 | May 15, 2025 | Armistice Capital, LLC | 13G/A | 7.6% | 6.57M | SEC |
| 10 | May 2, 2025 | Suvretta Capital Management, LLC | 13G/A | 9.4% | 7.56M | SEC |
54 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Kura Oncology Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 9.64M | $78.35M |
| 2 | Suvretta Capital Management, LLC | 8.58M | $69.72M |
| 3 | Bvf Inc/Il | 8.45M | $68.66M |
| 4 | State Street Corp | 4.51M | $36.68M |
| 5 | Armistice Capital, LLC | 3.74M | $30.37M |
| 6 | Prosight Management, LP | 3.36M | $27.29M |
| 7 | Deep Track Capital, LP | 2.64M | $21.49M |
| 8 | Aqr Capital Management LLC | 2.12M | $17.27M |
| 9 | Geode Capital Management, LLC | 2.03M | $16.54M |
| 10 | Qube Research & Technologies Ltd | 1.64M | $13.31M |